ClinicalTrials.gov
public full text
Public Domain
All Polyethylene Tibia-VEGA Kiel
Obligatory Post-Marketing Clinical Follow-up (PMCF) as part of the post marketing surveillance plan for the product under investigation For this PMCF only CE-marked medical devices will be used within their intended purpose and no additional invasive or other stressful examinations are to be carried out (acc. to MPG §23b).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- SECURE Post-Market Study#1363346
- WFPC7004 IPC Certificate in Commissioning and Purchasing for Public Care, ASD materials OER#1135923
- Acetazolamide for the Prevention of Post Operative CSF Leak#979356
- Italy – Other therapeutic products – Radiofarmaco 18 psma — ASL BAT (ITA) · 2565000 EUR#1099113
- VF Test for Prediction of Extremely PTB After Cerclage#1259749
Record · ID 1228833
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive